Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rothstein

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Antibiotics|October 6, 2007
In vitro activity of novel rifamycins against gram-positive clinical isolatesChristopher K Murphy, Elena Karginova, Dan Sahm, et al.
Transplantation|April 30, 2003
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathyMasayuki Sho, Hiroshi Harada, David M Rothstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 30, 2017
TIM-4 Identifies IFN-γ-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft RejectionQing Ding, Kanishka Mohib, Vijay K Kuchroo, et al.
Archiv Der Pharmazie|October 4, 2007
Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infectionsDavid M Rothstein, John van Duzer, Andrew Sternlicht, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infectionRobert J Suchland, Kara Brown, David M Rothstein, et al.
Clinics in Laboratory Medicine|February 3, 2019
Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?Aravind Cherukuri, Qing Ding, Akhil Sharma, et al.
The Journal of Antibiotics|April 25, 2006
In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureusMarcia S Osburne, David M Rothstein, Ronnie Farquhar, et al.
The Journal of Antibiotics|May 17, 2002
A pathway-specific cell based screening system to detect bacterial cell wall inhibitorsDongyu Sun, Seth Cohen, Nagraj Mani, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2019
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejectionAnita S Chong, David M Rothstein, Kassem Safa, et al.
Journal of Bacteriology|May 3, 2017
A Mutation in the Bacillus subtilis rsbU Gene That Limits RNA Synthesis during SporulationDavid M Rothstein, David Lazinski, Marcia S Osburne, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Antibiotics|October 6, 2007
In vitro activity of novel rifamycins against gram-positive clinical isolatesChristopher K Murphy, Elena Karginova, Dan Sahm, et al.
Transplantation|April 30, 2003
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathyMasayuki Sho, Hiroshi Harada, David M Rothstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 30, 2017
TIM-4 Identifies IFN-γ-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft RejectionQing Ding, Kanishka Mohib, Vijay K Kuchroo, et al.
Archiv Der Pharmazie|October 4, 2007
Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infectionsDavid M Rothstein, John van Duzer, Andrew Sternlicht, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infectionRobert J Suchland, Kara Brown, David M Rothstein, et al.
Clinics in Laboratory Medicine|February 3, 2019
Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?Aravind Cherukuri, Qing Ding, Akhil Sharma, et al.
The Journal of Antibiotics|April 25, 2006
In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureusMarcia S Osburne, David M Rothstein, Ronnie Farquhar, et al.
The Journal of Antibiotics|May 17, 2002
A pathway-specific cell based screening system to detect bacterial cell wall inhibitorsDongyu Sun, Seth Cohen, Nagraj Mani, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2019
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejectionAnita S Chong, David M Rothstein, Kassem Safa, et al.
Journal of Bacteriology|May 3, 2017
A Mutation in the Bacillus subtilis rsbU Gene That Limits RNA Synthesis during SporulationDavid M Rothstein, David Lazinski, Marcia S Osburne, et al.
Pageof 8